Flagship Harbor Advisors, LLC Concert Pharmaceuticals, Inc. Transaction History

Flagship Harbor Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 13, 2022	SELL	$4.27 - $7.2 $213 - $360	-50 Reduced 0.48%	10,350 $69,000
Q4 2021 Feb 10, 2022	SELL	$2.69 - $4.22 $9,415 - $14,770	-3,500 Reduced 25.18%	10,400 $33,000
Q2 2021 Jul 26, 2021	BUY	$3.77 - $5.24 $9,425 - $13,100	2,500 Added 21.93%	13,900 $59,000
Q1 2021 May 03, 2021	BUY	$4.86 - $13.07 $55,404 - $148,998	11,400 New	11,400 $57,000
Q4 2020 Feb 08, 2021	SELL	$9.48 - $12.84 $37,920 - $51,360	-4,000 Closed	0 $0
Q2 2020 Jul 31, 2020	SELL	$7.8 - $11.52 $3,120 - $4,608	-400 Reduced 9.09%	4,000 $39,000
Q1 2020 May 12, 2020	SELL	$5.98 - $13.09 $3,588 - $7,854	-600 Reduced 12.0%	4,400 $39,000
Q3 2019 Oct 22, 2019	BUY	$5.88 - $12.35 $18,228 - $38,285	3,100 Added 163.16%	5,000 $29,000
Q2 2018 Aug 14, 2018	BUY	$16.83 - $21.66 $31,976 - $41,154	1,900 New	1,900 $31,000

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Flagship Harbor Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Flagship Harbor Advisors, LLC with notifications on news.